Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Research article

Validation of the Oxford classification of IgA nephropathy for pediatric patients from China

Authors: Weibo Le, Cai-Hong Zeng, Zhangsuo Liu, Dong Liu, Qing Yang, Rui-Xia Lin, Zheng-Kun Xia, Zhong-Min Fan, Guanghua Zhu, Ying Wu, Hong Xu, Yihui Zhai, Ying Ding, Xiaoqing Yang, Shaoshan Liang, Hao Chen, Feng Xu, Qian Huang, Hongbing Shen, Jianming Wang, Agnes B Fogo, Zhi-Hong Liu

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations.

Methods

A total of 218 children with IgAN from 7 renal centers in China were enrolled. The inclusion criteria was similar to the original Oxford study.

Results

There were 98 patients (45%) with mesangial proliferation (M1), 51 patients (23%) with endocapillary proliferation (E1), 136 patients (62%) with segmental sclerosis/adhesion lesion (S1), 13 patients (6%) with moderate tubulointerstitial fibrosis (T1 26-50% of cortex scarred), and only 2 patients (1%) with severe tubulointerstitial fibrosis (T2, >50% of cortex scarred). During a median follow-up duration of 56 months, 24 children (12.4%) developed ESRD or 50% decline in renal function. In univariate COX analysis, we found that tubular atrophy/interstitial fibrosis (HR 4.3, 95%CI 1.8-10.5, P < 0.001) and segmental glomerulosclerosis (HR 9.2 1.2-68.6, P = 0.03) were significant predictors of renal outcome. However, mesangial hypercellularity, endocapillary proliferation, crescents, and necrosis were not associated with renal prognosis. In the multivariate COX regression model, none of these pathologic lesions were shown to be independent risk factors of unfavorable renal outcome except for tubular atrophy/interstitial fibrosis (HR 2.9, 95%CI 1.0-7.9 P = 0.04).

Conclusions

We confirmed tubular atrophy/interstitial fibrosis was the only feature independently associated with renal outcomes in Chinese children with IgAN.
Appendix
Available only for authorised users
Literature
1.
go back to reference D’Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004, 24 (3): 179-196. 10.1016/j.semnephrol.2004.01.001.CrossRefPubMed D’Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004, 24 (3): 179-196. 10.1016/j.semnephrol.2004.01.001.CrossRefPubMed
2.
go back to reference Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z: Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant. 2012, 27 (4): 1479-1485. 10.1093/ndt/gfr527.CrossRefPubMed Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z: Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant. 2012, 27 (4): 1479-1485. 10.1093/ndt/gfr527.CrossRefPubMed
3.
go back to reference Haas M: Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997, 29 (6): 829-842. 10.1016/S0272-6386(97)90456-X.CrossRefPubMed Haas M: Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997, 29 (6): 829-842. 10.1016/S0272-6386(97)90456-X.CrossRefPubMed
4.
go back to reference Radford MG, Donadio JV, Bergstralh EJ, Grande JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997, 8 (2): 199-207.PubMed Radford MG, Donadio JV, Bergstralh EJ, Grande JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997, 8 (2): 199-207.PubMed
5.
go back to reference Lee SM, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo BH, Katz AI: IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol. 1982, 13 (4): 314-322. 10.1016/S0046-8177(82)80221-9.CrossRefPubMed Lee SM, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo BH, Katz AI: IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol. 1982, 13 (4): 314-322. 10.1016/S0046-8177(82)80221-9.CrossRefPubMed
6.
go back to reference Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y: A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant. 2009, 24 (10): 3068-3074. 10.1093/ndt/gfp273.CrossRefPubMedPubMedCentral Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y: A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant. 2009, 24 (10): 3068-3074. 10.1093/ndt/gfp273.CrossRefPubMedPubMedCentral
7.
go back to reference Manno C, Strippoli GF, D’Altri C, Torres D, Rossini M, Schena FP: A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis. 2007, 49 (6): 763-775. 10.1053/j.ajkd.2007.03.013.CrossRefPubMed Manno C, Strippoli GF, D’Altri C, Torres D, Rossini M, Schena FP: A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis. 2007, 49 (6): 763-775. 10.1053/j.ajkd.2007.03.013.CrossRefPubMed
8.
go back to reference Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, et al: The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009, 76 (5): 534-545. 10.1038/ki.2009.243.CrossRefPubMed Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, et al: The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009, 76 (5): 534-545. 10.1038/ki.2009.243.CrossRefPubMed
9.
go back to reference Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, et al: The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009, 76 (5): 546-556. 10.1038/ki.2009.168.CrossRefPubMed Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, et al: The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009, 76 (5): 546-556. 10.1038/ki.2009.168.CrossRefPubMed
10.
go back to reference Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, Shimizu F, Nikolic-Paterson DJ, Uchiyama M: Histological differences in new-onset IgA nephropathy between children and adults. Nephrol Dial Transplant. 2006, 21 (12): 3466-3474. 10.1093/ndt/gfl455.CrossRefPubMed Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, Shimizu F, Nikolic-Paterson DJ, Uchiyama M: Histological differences in new-onset IgA nephropathy between children and adults. Nephrol Dial Transplant. 2006, 21 (12): 3466-3474. 10.1093/ndt/gfl455.CrossRefPubMed
11.
go back to reference Haas M, Rahman MH, Cohn RA, Fathallah-Shaykh S, Ansari A, Bartosh SM: IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes. Nephrol Dial Transplant. 2008, 23 (8): 2537-2545. 10.1093/ndt/gfn014.CrossRefPubMed Haas M, Rahman MH, Cohn RA, Fathallah-Shaykh S, Ansari A, Bartosh SM: IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes. Nephrol Dial Transplant. 2008, 23 (8): 2537-2545. 10.1093/ndt/gfn014.CrossRefPubMed
12.
go back to reference Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, et al: The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 2010, 77 (10): 921-927. 10.1038/ki.2010.43.CrossRefPubMed Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, et al: The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 2010, 77 (10): 921-927. 10.1038/ki.2010.43.CrossRefPubMed
13.
go back to reference Mina SN, Murphy WM: IgA nephropathy. A comparative study of the clinicopathologic features in children and adults. Am J Clin Pathol. 1985, 83 (6): 669-675.CrossRefPubMed Mina SN, Murphy WM: IgA nephropathy. A comparative study of the clinicopathologic features in children and adults. Am J Clin Pathol. 1985, 83 (6): 669-675.CrossRefPubMed
14.
go back to reference Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y: IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features. Am J Nephrol. 1990, 10 (3): 191-197. 10.1159/000168080.CrossRefPubMed Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y: IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features. Am J Nephrol. 1990, 10 (3): 191-197. 10.1159/000168080.CrossRefPubMed
15.
go back to reference Shi SF, Wang SX, Jiang L, Lv JC, Liu LJ, Chen YQ, Zhu SN, Liu G, Zou WZ, Zhang H, et al: Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol. 2011, 6 (9): 2175-2184. 10.2215/CJN.11521210.CrossRefPubMedPubMedCentral Shi SF, Wang SX, Jiang L, Lv JC, Liu LJ, Chen YQ, Zhu SN, Liu G, Zou WZ, Zhang H, et al: Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol. 2011, 6 (9): 2175-2184. 10.2215/CJN.11521210.CrossRefPubMedPubMedCentral
16.
go back to reference Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, et al: Validation of the Oxford classification of IgA nephropathy. Kidney Int. 2011, 80 (3): 310-317. 10.1038/ki.2011.126.CrossRefPubMed Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, et al: Validation of the Oxford classification of IgA nephropathy. Kidney Int. 2011, 80 (3): 310-317. 10.1038/ki.2011.126.CrossRefPubMed
17.
go back to reference Edstrom Halling S, Soderberg MP, Berg UB: Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Nephrol Dial Transplant. 2012, 27 (2): 715-722. 10.1093/ndt/gfr339.CrossRefPubMed Edstrom Halling S, Soderberg MP, Berg UB: Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Nephrol Dial Transplant. 2012, 27 (2): 715-722. 10.1093/ndt/gfr339.CrossRefPubMed
18.
go back to reference Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C: The use of the Oxford classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol. 2011, 6 (10): 2384-2388. 10.2215/CJN.01170211.CrossRefPubMedPubMedCentral Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C: The use of the Oxford classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol. 2011, 6 (10): 2384-2388. 10.2215/CJN.01170211.CrossRefPubMedPubMedCentral
19.
go back to reference Shima Y, Nakanishi K, Hama T, Mukaiyama H, Togawa H, Hashimura Y, Kaito H, Sako M, Iijima K, Yoshikawa N: Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol. 2012, 27 (5): 783-792. 10.1007/s00467-011-2061-0.CrossRefPubMed Shima Y, Nakanishi K, Hama T, Mukaiyama H, Togawa H, Hashimura Y, Kaito H, Sako M, Iijima K, Yoshikawa N: Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol. 2012, 27 (5): 783-792. 10.1007/s00467-011-2061-0.CrossRefPubMed
20.
go back to reference Yau T, Korbet SM, Schwartz MM, Cimbaluk DJ: The Oxford classification of IgA nephropathy: a retrospective analysis. Am J Nephrol. 2011, 34 (5): 435-444. 10.1159/000332223.CrossRefPubMed Yau T, Korbet SM, Schwartz MM, Cimbaluk DJ: The Oxford classification of IgA nephropathy: a retrospective analysis. Am J Nephrol. 2011, 34 (5): 435-444. 10.1159/000332223.CrossRefPubMed
21.
go back to reference Zeng CH, Le W, Ni Z, Zhang M, Miao L, Luo P, Wang R, Lv Z, Chen J, Tian J, et al: A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis. 2012, 60 (5): 812-820. 10.1053/j.ajkd.2012.06.011.CrossRefPubMed Zeng CH, Le W, Ni Z, Zhang M, Miao L, Luo P, Wang R, Lv Z, Chen J, Tian J, et al: A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis. 2012, 60 (5): 812-820. 10.1053/j.ajkd.2012.06.011.CrossRefPubMed
22.
go back to reference Kang SH, Choi SR, Park HS, Lee JY, Sun IO, Hwang HS, Chung BH, Park CW, Yang CW, Kim YS, et al: The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Nephrol Dial Transplant. 2012, 27 (1): 252-258. 10.1093/ndt/gfr295.CrossRefPubMed Kang SH, Choi SR, Park HS, Lee JY, Sun IO, Hwang HS, Chung BH, Park CW, Yang CW, Kim YS, et al: The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Nephrol Dial Transplant. 2012, 27 (1): 252-258. 10.1093/ndt/gfr295.CrossRefPubMed
23.
go back to reference D’Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, et al: Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med. 1986, 59 (228): 363-378.PubMed D’Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, et al: Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med. 1986, 59 (228): 363-378.PubMed
24.
go back to reference El Karoui K, Hill GS, Karras A, Moulonguet L, Caudwell V, Loupy A, Bruneval P, Jacquot C, Nochy D: Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int. 2011, 79 (6): 643-654. 10.1038/ki.2010.460.CrossRefPubMed El Karoui K, Hill GS, Karras A, Moulonguet L, Caudwell V, Loupy A, Bruneval P, Jacquot C, Nochy D: Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int. 2011, 79 (6): 643-654. 10.1038/ki.2010.460.CrossRefPubMed
25.
go back to reference Liu LJ, Li GT, Zhou Y, Lv JC, Zhang H: Clinicopathologic features and outcomes in endocapillary proliferative IgA nephropathy. Nephron Clin Pract. 2010, 115 (2): c161-c167. 10.1159/000312880.CrossRefPubMed Liu LJ, Li GT, Zhou Y, Lv JC, Zhang H: Clinicopathologic features and outcomes in endocapillary proliferative IgA nephropathy. Nephron Clin Pract. 2010, 115 (2): c161-c167. 10.1159/000312880.CrossRefPubMed
26.
go back to reference Lee H, Yi SH, Seo MS, Hyun JN, Jeon JS, Noh H, Han DC, Hwang SD, Jin SY, Kwon SH: Validation of the oxford classification of IgA nephropathy: a single-center study in korean adults. Korean J Intern Med. 2012, 27 (3): 293-300. 10.3904/kjim.2012.27.3.293.CrossRefPubMedPubMedCentral Lee H, Yi SH, Seo MS, Hyun JN, Jeon JS, Noh H, Han DC, Hwang SD, Jin SY, Kwon SH: Validation of the oxford classification of IgA nephropathy: a single-center study in korean adults. Korean J Intern Med. 2012, 27 (3): 293-300. 10.3904/kjim.2012.27.3.293.CrossRefPubMedPubMedCentral
27.
go back to reference D’Amico G, Napodano P, Ferrario F, Rastaldi MP, Arrigo G: Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. Kidney Int. 2001, 59 (2): 682-692. 10.1046/j.1523-1755.2001.059002682.x.CrossRefPubMed D’Amico G, Napodano P, Ferrario F, Rastaldi MP, Arrigo G: Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. Kidney Int. 2001, 59 (2): 682-692. 10.1046/j.1523-1755.2001.059002682.x.CrossRefPubMed
28.
go back to reference Hotta O, Furuta T, Chiba S, Tomioka S, Taguma Y: Regression of IgA nephropathy: a repeat biopsy study. Am J Kidney Dis. 2002, 39 (3): 493-502. 10.1053/ajkd.2002.31399.CrossRefPubMed Hotta O, Furuta T, Chiba S, Tomioka S, Taguma Y: Regression of IgA nephropathy: a repeat biopsy study. Am J Kidney Dis. 2002, 39 (3): 493-502. 10.1053/ajkd.2002.31399.CrossRefPubMed
29.
go back to reference Katafuchi R, Ninomiya T, Nagata M, Mitsuiki K, Hirakata H: Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation. Clin J Am Soc Nephrol. 2011, 6 (12): 2806-2813. 10.2215/CJN.02890311.CrossRefPubMedPubMedCentral Katafuchi R, Ninomiya T, Nagata M, Mitsuiki K, Hirakata H: Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation. Clin J Am Soc Nephrol. 2011, 6 (12): 2806-2813. 10.2215/CJN.02890311.CrossRefPubMedPubMedCentral
30.
go back to reference Barratt J, Feehally J: Primary IgA Nephropathy: new insights into pathogenesis. Semin Nephrol. 2011, 31 (4): 349-360. 10.1016/j.semnephrol.2011.06.006.CrossRefPubMed Barratt J, Feehally J: Primary IgA Nephropathy: new insights into pathogenesis. Semin Nephrol. 2011, 31 (4): 349-360. 10.1016/j.semnephrol.2011.06.006.CrossRefPubMed
Metadata
Title
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
Authors
Weibo Le
Cai-Hong Zeng
Zhangsuo Liu
Dong Liu
Qing Yang
Rui-Xia Lin
Zheng-Kun Xia
Zhong-Min Fan
Guanghua Zhu
Ying Wu
Hong Xu
Yihui Zhai
Ying Ding
Xiaoqing Yang
Shaoshan Liang
Hao Chen
Feng Xu
Qian Huang
Hongbing Shen
Jianming Wang
Agnes B Fogo
Zhi-Hong Liu
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-158

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.